KORES (INDIA) LIMITED
Contact Person:
Manufacturer of Active Pharmaceutical Ingredients : Theophylline [58-55-9], Etofylline [519-37-9], Doxofylline [69975-86-6], Acepifylline / Acefylline Piperazine /Theophylline Ethanoate Piperazine [18428-63-2 / 18833-33-1], Acefylline [652-37-9], Diprofylline / Dyfylline [479-18-5], Acebrophylline [179118-73-1], Ambroxol HCl [23828-92-4], Caffeine / Caffeine Granules [58-08-2], Gliclazide [21187-98-4], Glimepiride [93479-97-1], Pamabrom [606-04-2], Nautamine [6888-11-5], Orphenadrine [83-98-7], Orphenadrine Citrate [4682-35-4], Orphenadrine Hydrochloride [341-69-5], Cyclopentolate [512-15-2], Pharmaceutical Intermediates : 1-Methylbenzene-3.5-diacetonitrile [120511-74-2], 3.5-(2-Methylpropionitrilo) toluene [120511-72-0], 3.5-(2-Methylpropionitrilo) benzylbromide [120511-84-4],Ethyl-4.5-bis-(2-methoxyethoxy)-2-nitrobenzoate [179688-26-7], 3-Ethyl-4-methyl-2-oxopyrroline [766-36-9], 4-[2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-l) carboxamido]ethyl] benzenesulfonamide [119018-29-0], 6-Fluoro-3,4-dihydro-4-oxo-2H-1-benzopyran-2-carboxylic acid, 4-Phthalimidocyclohexanone [104618-32-8], 2,6-Diamino-4.5,6,7-tetrahydrobenzothiazole [104617-49-4], S(-) 2-amino-4.5,6,7-tetrahydro-6-aminobenzothiazole [106092-09-5], 2-Methyl benzhydrol [5472-13-9], 2-(1-hydroxy cyclopentyl)-2-phenyl acetic acid [25209-52-3], 2-Amino-3.5-dibromobenzaldehyde [50910-55-9], 8-Chloro Theophylline [85-18-7], 8-Benzyl Theophylline [2879-15-4], 8-Bromo Theophylline [10381-75-6], Theobromine [83-67-0], 3-Methylxanthine [1076-22-8], 3-Methyl-7-n-propyl xanthine [55242-64-3], 2-Bromoethyl-1,3-dioxolane [4360-63-8], 2-Bromo-1,1-dimethoxyethane [7252-83-7], 6-Amino-1,3-dimethyluracil [6642-31-5], 6-Chloro-1,3-dimethyluracil [6872-27-6], 6-Amino-1-methyl-5-propylaminouracil [125092-42-4]